Self-administration of drug combinations: Polydrug abuse

药物组合的自我给药：多种药物滥用

• 批准号: 7577494
• 负责人: William L. Woolverton
• 金额: $ 31.27万
• 依托单位: UNIVERSITY OF MISSISSIPPI MED CTR
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-03-01 至 2011-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7577494
• 关键词: Agonist; Animal Model; Barbiturates; Basic Science; Behavioral; Central Nervous System Depressants; Cocaine; Collection; Complex; Data Collection; Detection; Development; Dose; Drug Combinations; Drug Interactions; Drug Kinetics; Drug abuse; Foundations; Government; Human; Laboratories; Laboratory Research; Ligands; Modeling; Nature; Neurobiology; Opioid; Pharmaceutical Preparations; Public Health; Research; Research Personnel; Self Administration; Staging; Techniques; Testing; Time; barbituric acid salt; design; dopamine transporter; drug of abuse; epidemiologic data; improved; multidrug abuse; neurobehavioral; nonhuman primate; pre-clinical; programs; receptor; research study; response; therapy development; treatment strategy

Polydrug abuse is a serious public health problem in the US and elsewhere, though our understanding of the mechanisms controlling polydrug abuse is limited. Laboratory research can help establish more precisely these mechanisms and, thereby, contribute to rational approaches to the development of interventions. The research outlined in this proposal will use a laboratory model, drug self-administration by non-human primates, and current pharmacological approaches to understanding drug interactions, to study the self- administration of drag combinations. More particularly, we will test the overarching hypothesis that super- addictive reinforcing effects contribute to the abuse of the most problematic drag-combinations. To test this hypothesis, we will first study drag combinations selected to provide basic information about self-administration of combinations and to establish our analytical approach. Specific Aim 1 is to study the reinforcing effects of combinations of drags with comparable mechanisms of action. Two stimulants (dopamine transporter ligands) will be studied alone and in combination, as will two opioids (ji receptor agonists) and two depressants (barbiturates). We hypothesize that drags within a pharmacological class will be additive in terms of reinforcing effects. Specific Aim 2 is to examine combinations of drags across pharmacological class, i.e., with different mechanisms of action. Stimulant-opioid, stimulant-depressant and opioid-depressant combinations will be studied. We hypothesize that across pharmacological class (e.g., stimulant/opioid) these combinations will be non-additive in terms of reinforcing effects. Specific Aim 3 is to examine commonly abused combinations of cocaine with other drags. The hypothesis of this aim is that the combinations that are most problematic in humans are super-additive in their reinforcing effects. The studies in this proposal are designed with the aim of developing a framework for establishing a broadly applicable animal model of polydrag abuse. In this respect, our model should facilitate understanding neurobehavioral underpinnings of the reinforcing effects of drag combinations. Moreover, our model should provide key information for the development of improved strategies for the treatment of polydrag abuse.

多种药物滥用在美国和其他地方是一个严重的公共卫生问题，尽管我们对药物滥用的理解是， 控制多种药物滥用的机制有限。实验室研究可以帮助更精确地建立 这些机制，从而有助于制定干预措施的合理办法。 该提案中概述的研究将使用实验室模型，即非人类自我给药 灵长类动物，和目前的药理学方法，以了解药物相互作用，研究自我， 药物组合的施用。更具体地说，我们将测试的总体假设，超- 成瘾性强化作用导致最有问题的药物组合的滥用。 为了检验这一假设，我们将首先研究选定的阻力组合，以提供有关 自我管理的组合，并建立我们的分析方法。具体目标1是研究 具有类似作用机制的药物组合的增强作用。两种兴奋剂 （多巴胺转运蛋白配体）将单独和联合研究，两种阿片类药物（Ji受体）也将如此。 激动剂）和两种抑制剂（巴比妥酸盐）。我们假设药物类别中的药物 在增强效果方面是相加的。具体目标2是检查阻力的组合， 药理学类别，即，不同的作用机制。阿片类兴奋剂、阿片类兴奋剂和 将研究阿片类药物与阿片类药物的组合。我们假设，在药理学类别中（例如， 兴奋剂/阿片样物质），这些组合在增强效果方面将是非加和的。具体目标3是 检查可卡因与其他药物的常见滥用组合。这一目标的假设是， 在人类中最成问题的组合在其强化效果上是超级加和的。 本提案中的研究旨在制定一个框架， 广泛适用的多药滥用动物模型。在这方面，我们的模式应有助于理解 药物组合强化效应的神经行为基础。此外，我们的模型应该 为制定治疗多药滥用的改进战略提供关键信息。